Abstract
Objective(s) To determine the causal relationship between exposure to early hyperoxaemia and death/disability in infants with hypoxic-ischemic encephalopathy (HIE).
Study design We analyzed data from the Infant Cooling Evaluation (ICE) trial that enrolled newborns ≥35 weeks’ gestation with moderate-severe HIE, randomly allocated to hypothermia or normothermia. The primary outcome was death or major sensorineural disability at 2 years. We included infants with arterial pO2 measured within 2 h of birth. Using a directed acyclic graph, we established that markers of severity of perinatal hypoxia-ischemia and pCO2 were a minimally sufficient set of variables for adjustment in a regression model to estimate the causal relationship between arterial pO2 and death/disability.
Results Among 221 infants, 116 (56%) had arterial pO2 and primary outcome data. The unadjusted analysis revealed a U-shaped relationship between arterial pO2 and death/disability. Among hyperoxaemic infants (pO2 100–500 mmHg) the risk of death/disability was 40/58 (0.69), while the risk in normoxaemic infants (pO2 40 – 99mmHg) was 20/48 (0.42). In the adjusted model, hyperoxaemia increased the risk of death/disability (adjusted risk ratio 1.61, 95% CI 1.07 – 2.00, p= 0.03) in relation to normoxaemia.
Conclusions Early hyperoxaemia increased the risk of death/disability among infants who had an early arterial pO2 in the ICE trial. Limitations include the possibility of residual confounding and other causal biases. Further work is warranted to confirm this relationship in the era of routine therapeutic hypothermia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the National Health and Medical Research Council (NHMRC) Australia.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Research Ethics Office of the Royal Childrens Hospital Melbourne Australia waived ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
List of abbreviations
- (SpO2)
- Arterial oxygen saturation
- (BSID-II)
- Bayley Scales of Infant Development II
- (CP)
- cerebral palsy
- (CPR)
- cardiopulmonary resuscitation
- (DAG)
- Directed acyclic graph
- (FiO2)
- fraction of inspired oxygen
- (HIE)
- hypoxic ischemic encephalopathy
- (pO2)
- partial pressure of oxygen
- (pCO2)
- partial pressure of carbon dioxide
- (GMFCS)
- Gross Motor Function Classification System.
